| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 11.6% | 12.0% | ▲ +0.4% |
| Banks | 8.2% | 9.9% | ▲ +1.7% |
| Industrial Products | 9.9% | 9.4% | ▼ -0.5% |
| Capital Markets | 6.1% | 7.3% | ▲ +1.2% |
| Finance | 8.0% | 6.7% | ▼ -1.3% |
| Cement & Cement Products | 5.6% | 5.2% | ▼ -0.4% |
| IT - Software | 4.8% | 4.8% | ● 0.0% |
| Automobiles | 4.6% | 4.5% | ▼ -0.2% |
| Consumer Durables | 3.3% | 3.6% | ▲ +0.3% |
| Chemicals & Petrochemicals | 2.8% | 3.3% | ▲ +0.6% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 12.0% | 9.6% | ▼ -2.5% |
| Banks | 9.9% | 9.5% | ▼ -0.4% |
| Industrial Products | 9.4% | 9.2% | ▼ -0.2% |
| Finance | 6.7% | 6.9% | ▲ +0.2% |
| Capital Markets | 7.3% | 6.8% | ▼ -0.5% |
| IT - Software | 4.8% | 6.0% | ▲ +1.2% |
| Cement & Cement Products | 5.2% | 4.9% | ▼ -0.4% |
| Automobiles | 4.5% | 4.4% | ● -0.1% |
| Metals & Minerals Trading | 3.1% | 3.8% | ▲ +0.8% |
| Chemicals & Petrochemicals | 3.3% | 3.3% | ● -0.1% |
Comparing Apr 2026 → May 2026
| # | Stock | Sector | Last Weight (Apr 2026) |
|---|---|---|---|
| 1 | Vedanta Limited ₹48.88 Cr |
Diversified Metals | 0.76% |
| 2 | ICICI Prudential Asset Management Company Limited ₹16.54 Cr |
Capital Markets | 0.26% |
| # | Stock | Sector | Apr 2026 | May 2026 | Change |
|---|---|---|---|---|---|
| 1 | Adani Enterprises Limited ₹210.02 Cr |
Metals & Minerals Trading | 2.39% | 3.16% | +0.77% |
| 2 | Mphasis Limited ₹120.38 Cr |
IT - Software | 1.24% | 1.81% | +0.57% |
| 3 | JSW Steel Limited ₹62.50 Cr |
Ferrous Metals | 0.39% | 0.94% | +0.55% |
| 4 | Tech Mahindra Limited ₹59.36 Cr |
IT - Software | 0.46% | 0.89% | +0.43% |
| 5 | Vodafone Idea Limited ₹111.22 Cr |
Telecom - Services | 1.26% | 1.67% | +0.41% |
| 6 | Tata Steel Limited ₹59.11 Cr |
Ferrous Metals | 0.49% | 0.89% | +0.40% |
| 7 | Laurus Labs Limited ₹149.82 Cr |
Pharmaceuticals & Biotechnology | 1.88% | 2.26% | +0.38% |
| 8 | InterGlobe Aviation Limited ₹133.25 Cr |
Transport Services | 1.67% | 2.01% | +0.34% |
| 9 | Infosys Limited ₹66.85 Cr |
IT - Software | 0.71% | 1.01% | +0.30% |
| 10 | Max Financial Services Limited ₹66.96 Cr |
Insurance | 0.74% | 1.01% | +0.27% |
| # | Stock | Sector | Apr 2026 | May 2026 | Change |
|---|---|---|---|---|---|
| 1 | Glenmark Pharmaceuticals Limited ₹84.63 Cr |
Pharmaceuticals & Biotechnology | 3.70% | 1.27% | -2.43% |
| 2 | Multi Commodity Exchange of India Limited ₹23.51 Cr |
Capital Markets | 1.06% | 0.35% | -0.71% |
| 3 | Sai Life Sciences Limited ₹49.82 Cr |
Pharmaceuticals & Biotechnology | 1.38% | 0.75% | -0.63% |
| 4 | Aditya Vision Ltd ₹31.42 Cr |
Retailing | 1.01% | 0.47% | -0.54% |
| 5 | Voltamp Transformers Limited ₹96.13 Cr |
Electrical Equipment | 1.85% | 1.45% | -0.40% |
| 6 | Polycab India Limited ₹145.48 Cr |
Industrial Products | 2.43% | 2.19% | -0.24% |
| 7 | State Bank of India ₹110.91 Cr |
Banks | 1.91% | 1.67% | -0.24% |
| 8 | Kajaria Ceramics Limited ₹65.96 Cr |
Consumer Durables | 1.23% | 0.99% | -0.24% |
| 9 | P N Gadgil Jewellers Limited ₹54.70 Cr |
Consumer Durables | 1.02% | 0.82% | -0.20% |
| 10 | Sun TV Network Limited ₹49.66 Cr |
Entertainment | 0.93% | 0.75% | -0.18% |
80 stocks — May 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹214.61 Cr |
Construction |
3.23%
|
|
| 2 |
₹210.02 Cr |
Metals & Minerals Trading |
3.16%
|
|
| 3 |
₹190.01 Cr |
Pharmaceuticals & Biotechnology |
2.86%
|
|
| 4 |
₹165.84 Cr |
Capital Markets |
2.50%
|
|
| 5 |
₹160.17 Cr |
Pharmaceuticals & Biotechnology |
2.41%
|
|
| 6 |
₹149.82 Cr |
Pharmaceuticals & Biotechnology |
2.26%
|
|
| 7 |
₹145.48 Cr |
Industrial Products |
2.19%
|
|
| 8 |
₹143.53 Cr |
Cement & Cement Products |
2.16%
|
|
| 9 |
₹142.46 Cr |
Capital Markets |
2.14%
|
|
| 10 |
₹142.23 Cr |
Finance |
2.14%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.